SEC EDGAR Filing Information

Form 8-K12G3 -- Notification of securities of successor issuers deemed to registered [Section 12]

Period of Report: 2009-03-23
Filing Date Changed: 2009-03-24
Documents: 6

SEC Accession No.
0000936392-09-000132
Filing date: 2009-03-25
Accepted: 2009-03-24 20:51:59

Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Table of submitted documents:

Seq	Type	Document	Size	Description
1	8-K12G3	a51896e8vk12g3.htm	37549	FORM 8-K12G3
2	EX-3.1	a51896exv3w1.htm	12698	EX-3.1
3	EX-3.2	a51896exv3w2.htm	89729	EX-3.2
4	EX-3.3	a51896exv3w3.htm	11969	EX-3.3
5	EX-4.1	a51896exv4w1.htm	19778	EX-4.1
6	GRAPHIC	a51896a5189602.jpg	775466	GRAPHIC

		0000936392-09-000132.txt	1242168	Complete submission text file

Filer Information:

AVANIR PHARMACEUTICALS (Filer) (0000858803)
IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 8-K12G3 | Act: 34 | File No.: 000-18734 | Film No.: 09702674
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656
949-389-6700

Mailing Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656